Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:18 pm Purchase | 2023-12-31 | 13G | Intuitive Machines, Inc. LUNR | Citadel Advisors LLC | 843,505 3.900% | 843,505 (New Position) | Filing History |
| 2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Appreciate Holdings, Inc. SFRT | Citadel Advisors LLC | 965,611 5.400% | -154,481 (-13.79%) | Filing History |
| 2024-02-14 6:18 pm Purchase | 2023-12-31 | 13G | Acelyrin, Inc. SLRN | Citadel Advisors LLC | 6,649,442 6.800% | 685,642 (+11.50%) | Filing History |
| 2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Benitec Biopharma Inc. BNTC | Citadel Advisors LLC | 95,356 3.600% | -84,674 (-47.03%) | Filing History |
| 2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Clene Inc. CLNN | Citadel Advisors LLC | 302,516 4.500% | -78,703 (-20.65%) | Filing History |
| 2024-02-14 6:18 pm Sale | 2023-12-31 | 13G | Applied Optoelectronics, Inc. AAOI | Citadel Advisors LLC | 506,340 1.200% | -1,324,593 (-72.35%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE | Citadel Advisors LLC | 94 0.000% | -44,534 (-99.79%) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Dianthus Therapeutics, Inc. DNTH | Citadel Advisors LLC | 2,880 0.000% | 2,880 (New Position) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | FIGS, Inc. FIGS | Citadel Advisors LLC | 611,989 0.400% | -8,605,659 (-93.36%) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | AlTi Global, Inc. ALTI | Citadel Advisors LLC | 441 0.000% | 441 (New Position) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Inflection Point Acquisition Corp. II IPXX | Citadel Advisors LLC | 3,666 0.000% | 3,666 (New Position) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Alchemy Investments Acquisition Corp 1 ALCY | Citadel Advisors LLC | 1,985 0.000% | 1,985 (New Position) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | 2seventy bio, Inc. TSVT | Citadel Advisors LLC | 146,401 0.300% | -2,445,205 (-94.35%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Arhaus, Inc. ARHS | Citadel Advisors LLC | 450,504 0.900% | -2,437,203 (-84.40%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Citadel Advisors LLC | 1,236,850 2.400% | -1,022,891 (-45.27%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Semper Paratus Acquisition Corporation LGST | Citadel Advisors LLC | 5,846 0.000% | -927,608 (-99.37%) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Enliven Therapeutics, Inc. ELVN | Citadel Advisors LLC | 2,394,448 5.800% | 95,692 (+4.16%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Annexon, Inc. ANNX | Citadel Advisors LLC | 1,069,087 1.400% | -1,431,220 (-57.24%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Citadel Advisors LLC | 390,512 0.700% | -2,292,302 (-85.44%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Design Therapeutics, Inc. DSGN | Citadel Advisors LLC | 1,834,854 3.300% | -1,036,413 (-36.10%) | Filing History |